Governance and Management - The board consists of eight directors, including three independent non-executive directors, promoting strict review and monitoring processes[5] - The company has established a risk management and internal control policy, with an annual review of the effectiveness of the internal control system conducted by the board[12] - The independent non-executive directors believe that the risk management and internal control systems are sufficient and effective, with adequate resources allocated for accounting, internal audit, and financial reporting functions[13] - The company has adopted a governance code that includes recommendations on the remuneration of individual executive directors and senior management[1] - The company has a diverse board in terms of gender, age, educational background, professional experience, skills, knowledge, and tenure[5] - The company has implemented strict measures to prevent unauthorized use of confidential or insider information, ensuring compliance with governance standards[42] Stakeholder Engagement - The company encourages shareholders to actively participate in the annual general meeting and other shareholder meetings, ensuring they have sufficient time to consider the resolutions presented[16] - The company has confirmed its main stakeholders, including employees, consumers, suppliers, distributors, shareholders, investors, government, and the broader community, and has established multiple communication channels for them[28] Environmental Management - The company has implemented a three-tier environmental management network to ensure environmental management decisions and systems are fully implemented at all levels[31] - The company is committed to addressing ESG issues, evaluating their importance from both business impact and stakeholder perspectives[25] - The company achieved ISO 14000 environmental management system certification in 2022 and was recognized as a national "Green Factory" in 2023, with a total of 1,491 companies receiving this honor nationwide[33] - The company is actively pursuing various environmental management certifications to enhance its core competitiveness in energy-saving and low-carbon operations[33] - The total wastewater discharge in 2023 was 195,285.9 tons, a decrease from 251,062.1 tons in 2022, representing a reduction of approximately 22.2%[89] - The company reported a total greenhouse gas emissions of 6,948.888 tons of CO₂ in 2023, an increase from 4,572.734 tons in 2022, reflecting a rise of approximately 52%[78] - The average water consumption intensity in 2023 was 3.74 tons per ten thousand yuan of output, down from 5.68 tons in 2022, indicating a reduction of approximately 34.2%[74] - The company has established a specialized energy management team to oversee energy consumption, with a focus on reducing energy usage and improving efficiency[70] - The total solid waste generated includes various categories, with general solid waste primarily sent to landfills, while some are utilized for agricultural fertilizer[67] - The company has implemented advanced wastewater treatment technologies, including an IC reactor, to ensure compliance with environmental standards[60] - The nitrogen oxide emissions in 2023 were recorded at 1.063 tons, a decrease from 1.792 tons in 2022, showing a reduction of approximately 40.6%[65] - The company aims to achieve carbon neutrality by transitioning from coal-fired boilers to natural gas boilers and investing in renewable energy sources[81] - The total energy consumption data for the past three years indicates a structured approach to energy management, with specific targets set for reduction[72] Financial Performance - The company's total revenue for the year ended December 31, 2023, was RMB 565.6 million, representing a 15.0% increase from RMB 491.8 million in the previous year[37] - The sales of the main product, Shuanghuanglian Oral Liquid, accounted for 48.9% of total revenue, with sales reaching RMB 275.8 million, up 16.7% from RMB 236.4 million[37] - The gross profit margin remained stable, with sales costs for the year ending December 31, 2023, approximately RMB 266.1 million, compared to RMB 266.7 million in the previous year[39] - The sales of Shuanghuanglian Injection increased by 32.7%, reaching RMB 98.0 million, contributing 17.3% to total revenue[37] - The company reported a significant increase of 104.9% in sales of Qingre Jiedu Oral Liquid, which generated RMB 48.6 million, accounting for 8.6% of total revenue[37] - Third-party product sales decreased by 34.3%, totaling RMB 15.0 million, which represented 2.6% of total revenue[37] - The company's revenue for 2023 was RMB 565.6 million, representing a 15% increase compared to RMB 491.8 million in 2022[112][121] - Gross profit for 2023 was RMB 299.5 million, up 33.1% from RMB 225.0 million in 2022, with a gross margin increase from 45.8% to 53.0%[112][119] - The net loss for 2023 was approximately RMB 36.3 million, an increase of about 4.6% compared to a net loss of RMB 34.7 million in 2022[118] Research and Development - Research and development expenses for 2023 were approximately RMB 65.2 million, significantly up from RMB 15.2 million in 2022, marking an increase of about RMB 50 million[119] - The company is currently working on 50 R&D projects, including 31 drug formulation projects and 12 chemical raw material projects, with plans to submit around ten product registration applications in 2024[119][120] - The company reported a significant increase in R&D expenditure, amounting to approximately RMB 65.2 million in 2023, up from RMB 15.2 million in 2022, representing an increase of about RMB 50 million[136] - Currently, the company has a total of 50 ongoing R&D projects, including 31 generic drug projects, 12 active pharmaceutical ingredient projects, and 7 traditional Chinese medicine projects[136] - The company anticipates submitting around 10 new drug applications in 2024, with 4 projects currently under review[136] Employee Management and Training - The company employs 1,148 staff members, with a balanced gender ratio and a significant portion (91%) of employees from the local area, supporting local employment[85] - The company has established a collective agreement with the labor union, covering aspects such as labor remuneration, working hours, and employee benefits[124] - The company emphasizes equal employment practices, adhering strictly to national labor laws and policies, ensuring no discrimination based on ethnicity, gender, or religion[123] - The company has implemented a comprehensive safety management system, including regular safety training and inspections to mitigate potential risks in production[138] - The company is committed to a diverse talent development strategy, utilizing various methods for talent acquisition and collaboration[133] - The company has established a safety production leadership team to oversee safety affairs and ensure compliance with safety regulations[139] - In 2023, the company invested RMB 643,300 in safety production and RMB 4,777,400 in employee occupational health and safety, achieving a 100% employee health check rate[172] - The company maintained a safety training rate of 100% in 2023, with 440 employees participating in safety training[179] - The company has not experienced any major occupational health incidents or work-related injuries in 2023, consistent with the previous two years[172] - The company emphasizes fair and transparent talent management, ensuring equal opportunities for all employees regardless of background[157] - The company implemented a comprehensive training plan for 2023, focusing on enhancing employees' professional skills and operational capabilities[196] - The company has established a three-tier safety education training system, ensuring all new employees undergo safety training before starting work[179] - The company allocated resources to psychological care training and labor protection training for female employees in 2023[174] - The company’s employee training participation has been categorized by gender and job level, reflecting a commitment to diversity in development[177][178] - The company’s safety management system is aligned with national laws and regulations, enhancing overall workplace safety awareness[160] - The company has a mechanism for continuous training and development, aimed at improving employee capabilities and contributing to corporate growth[196] - In 2023, the number of male employees receiving training increased to 576, up from 269 in 2022, representing a growth of 114%[198] - The number of female employees receiving training slightly decreased to 572 in 2023 from 590 in 2022, a decline of 3%[198] - Senior management training participation rose to 27 in 2023, compared to 26 in 2022, an increase of 3.8%[198] - The number of middle management employees receiving training decreased to 90 in 2023 from 103 in 2022, a decline of 12.6%[198] - Training hours for both male and female employees remained consistent at 48 hours in 2023[198] - Senior management maintained a consistent training duration of 60 hours across the years 2021 to 2023[198] - The company emphasizes ongoing safety production education to enhance employee awareness and compliance with regulations[199] - The company has established a comprehensive safety production management system that includes safety goals in production plans and requirements in work assignments[200]
福森药业(01652) - 2023 - 年度财报